Sweden· SE-20140603000084
Innohep 12 000 anti-Xa IE Injektionsvätska, lösning i förfylld spruta
A medicinal product containing tinzaparin, registered in Sweden by LEO Pharma AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Tinzaparin
- Manufacturer
- LEO Pharma AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20140603000084
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tinzaparin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomInnohep 10,000units/0.5ml solution for injection pre-filled syringesLEO Pharma
- NetherlandsInnohep 10.000 IE anti-Xa/0,5 ml, oplossing voor injectieEuro Registratie Collectief B.V.
- SpainINNOHEP 10.000 UI ANTI-XA/0,5 ML SOLUCION INYECTABLE EN JERINGAS PRECARGADASLeo Pharma A/S
- ItalyINNOHEP*10 siringhe 12.000 UI 0,6 mlLEO PHARMA A/S
- FranceINNOHEP 10 000 UI anti-Xa/0,5 ml, solution injectable en seringue préremplieLABORATOIRES LEO
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Greece · Innohep
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c27aa96a-30fe-4df3-8171-b9a59190de84 GET /v1/drugs/c27aa96a-30fe-4df3-8171-b9a59190de84?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PAR",
"PL",
"SmPC"
],
"se_npl_id": "20140603000084",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140603000084",
"product_doc_link": "https://docetp.mpa.se/LMF/Innohep%2020%20000%20anti-Xa%20IU%20per%20ml%20solution%20for%20injection%20SmPC_09001bee807a472e.pdf"
}See everything about tinzaparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.